GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » Equity-to-Asset

BPH Global (ASX:BP8) Equity-to-Asset : -0.27 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is BPH Global Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BPH Global's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$-0.28 Mil. BPH Global's Total Assets for the quarter that ended in Dec. 2023 was A$1.04 Mil.

The historical rank and industry rank for BPH Global's Equity-to-Asset or its related term are showing as below:

ASX:BP8' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.27   Med: 0.6   Max: 0.99
Current: -0.27

During the past 13 years, the highest Equity to Asset Ratio of BPH Global was 0.99. The lowest was -0.27. And the median was 0.60.

ASX:BP8's Equity-to-Asset is ranked worse than
91.34% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs ASX:BP8: -0.27

BPH Global Equity-to-Asset Historical Data

The historical data trend for BPH Global's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BPH Global Equity-to-Asset Chart

BPH Global Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.44 0.60 0.40 0.01

BPH Global Semi-Annual Data
Dec07 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.40 0.40 0.01 -0.27

Competitive Comparison of BPH Global's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BPH Global's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BPH Global's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BPH Global's Equity-to-Asset falls into.



BPH Global Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BPH Global's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )=Total Stockholders Equity/Total Assets
=0.02/1.473
=

BPH Global's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-0.276/1.043
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BPH Global  (ASX:BP8) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


BPH Global Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BPH Global's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BPH Global (ASX:BP8) Business Description

Traded in Other Exchanges
N/A
Address
96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd, formerly Stemcell United Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and Greater China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.

BPH Global (ASX:BP8) Headlines

No Headlines